Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study-Reference-Cited by-同舟云学术

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Published:2015-02 Issue:2 Volume:16 Page:152-160
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ryan Charles J,Smith Matthew R,Fizazi Karim,Saad Fred,Mulders Peter F A,Sternberg Cora N,Miller Kurt,Logothetis Christopher J,Shore Neal D,Small Eric J,Carles Joan,Flaig Thomas W,Taplin Mary-Ellen,Higano Celestia S,de Souza Paul,de Bono Johann S,Griffin Thomas W,De Porre Peter,Yu Margaret K,Park Youn C,Li Jinhui,Kheoh Thian,Naini Vahid,Molina Arturo,Rathkopf Dana E

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

3. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 1130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Prostate Cancer: Sequential or Combination Therapy?;Clinical Genitourinary Cancer;2024-12

2. Real-life Data on First- and Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer With Abiraterone, Enzalutamide and Cabazitaxel – A multicentric Study From Portugal;Clinical Genitourinary Cancer;2024-12

3. Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer;Clinical and Translational Oncology;2024-09-12

4. Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-05

5. Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race;ClinicoEconomics and Outcomes Research;2024-09